Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +751.11%
#3 ADO Protocol ADO Protocol +101.14%
#4 Cortex Cortex +92.99%
#5 Ontology Gas Ontology Gas +77.68%
#6 Kinesis Silver Kinesis Silver +54.16%
#7 OpenEden OpenEden +35.10%
#8 Biconomy Biconomy +28.11%
#9 Magma Finance Magma Finance +26.20%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Viking Therapeutics, Inc. Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

VKTX
Rangering i aksjer #4213
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Aksjekurs
$34.45
Markedsverdi
$4.02B
Endring (1 dag)
0.83%
Endring (1 år)
32.31%
Land
US
Handel Viking Therapeutics, Inc. (VKTX)

Kategori

Healthcare
Aksjeprishistorikk for Viking Therapeutics, Inc. (VKTX)
Høyeste sluttskurs: $33.94 den 2026-08-01

Laveste sluttskurs: $8.59 den 2015-04-01
Aksjeprishistorikk for Viking Therapeutics, Inc. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -9.08%
2025 -20.83%
2024 152.59%
2023 215.71%
2022 16.84%
2021 -21.08%
2020 -20.48%
2019 -10.51%
2018 130.53%
2017 246.93%
2016 -60.36%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.84 42.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.13%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $147.64 496.99%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 6.25%
CH